Journals / Turkish Neurosurgery / 2018 / Cilt: 28 - Sayı: 5

Should Macular Lesions Accompanying Spinal Dysraphism be Excised? Analysis of Macular Lesions Accompanying Spinal Dysraphism

Pages
811–819
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

By preservingthese macular lesions, the creation of larger defects during excision is avoided.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To characterize the macular lesions associated with spinal dysraphism and to determine the outcomes of cases in whichmacular lesions are not excised.MATERIAL and METHODS: The patient cohort comprised 17 patients with spinal dysraphism who were treated at Mersin UniversityHospital from 2005 through 2007.
📊
Key Findings & Data:Blood and tissue samples were obtained from these patients.RESULTS:Electron microscopy results of tissue samples obtained from macular lesions are not consistent with those of hemangiomas.Increased numbers of vessels and significant dilatation was noted upon examination by light microscopy.
💡
Conclusion & Impact:By preservingthese macular lesions, the creation of larger defects during excision is avoided.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Özet

AIM: To characterize the macular lesions associated with spinal dysraphism and to determine the outcomes of cases in whichmacular lesions are not excised.MATERIAL and METHODS: The patient cohort comprised 17 patients with spinal dysraphism who were treated at Mersin UniversityHospital from 2005 through 2007. Blood and tissue samples were obtained from these patients.RESULTS:Electron microscopy results of tissue samples obtained from macular lesions are not consistent with those of hemangiomas.Increased numbers of vessels and significant dilatation was noted upon examination by light microscopy. The number of mast cellnumbers, blood estradiol levels, expression of tissue inhibitor matrix metalloproteinase-1 (TIMP-1) and vascular endothelial growthfactor (VEGF), and dermal collagen fiber diameter were within normal range. Estrogen receptor-β was not expressed. The numberof endothelial cells expressing Von-Willebrand factor was higher in the macular lesions.CONCLUSION: The characteristics of macular lesions associated with spinal dysraphism are consistent with those of capillarymalformations. We believe that the preservation of these macular lesions during soft tissue reconstruction of spinal dysraphismdefects, either by mobilization on a flap or primary closure, does not compromise the viability of the macular region. By preservingthese macular lesions, the creation of larger defects during excision is avoided.

🔖

Cite This Article

TUTUNCU, N., TENEKECİ, G., ÜNAL, Ş., YILMAZ, N., BAĞDATOĞLU, C. (2018). Should Macular Lesions Accompanying Spinal Dysraphism be Excised? Analysis of Macular Lesions Accompanying Spinal Dysraphism. Turkish Neurosurgery, Cilt: 28 - Sayı: 5, 811–819. https://ajindex.com/articles/404476

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Au KS, Northruo H, Kirkpatrick TJ, Volcik KA, Fletcher JM, Townsend IT, Blanton SH, Tyerman GH, Villarreal G, King TM: Promoter genotype of the platelet- derived growth factor receptor-alpha gene shows population stratification but not association with spina bifida meningomyelocele. Am J Med Genet A 139: 194–198, 2005
  2. Basterzi Y, Tenekeci G: Dorsal intercostal artery perforator propeller flaps: A reliable option in reconstruction of large meningomyelocele defects. Ann Plast Surg 76(4):434-437, 2016
  3. Cologlu H, Ozkan B, Uysal AC, Çologlu O, Borman H: Bilateral propeller flap closure of large meningomyelocele defects. Ann Plast Surg 73(1):68-73, 2014
  4. Copp AJ, Santier P, Greene NDE: Neural tube defects-recent advances, unsolved questions and controversies. Lancet Neurol 12(8):799-810, 2013
  5. El-Sabbagh AH, Zidan AS: Closure of large myelomeningocele defects by lumbar artery perforator flaps. J Reconstr Microsurg 27(5):287-294, 2011
  6. Finley JL, Clark RA, Colvin RB, Blackman R, Noe J, Rosen S: Immunofluorescent staining with antibodies to factor VIII, fibronectin, and, collagenous basement membrane protein in normal human skin and port wine stains. Arch Dermatol 118: 971-975, 1982
  7. Finn MC, Glowacki J, Mulliken JB: Congenital vascular lesions: Clinical application of a new classification. J Pediatr Surg 18: 894-900, 1983 Folkman J: Clinical application of research on angiogenesis. New Engl J Med 333:757-1763, 1995
  8. Folkman J, Klagsburn M: Angiogenic factors. Science 235: 442-447, 1987
  9. Glowacki J, Mulliken JB: Mast cells in hemangiomas and vascular malformations. Pediatrics 70(1):48-51, 1982
  10. Hill SM, Elwood ET, Lin J: Closure of meningomyelocele defects using acellular dermal matrix. J Neurosurg Pediatrics 9: 156-160, 2012
  11. Isik D, Tekes L, Eseoglu M, Isik Y, Bilici S, Atik B: Closure of large myelomeningocele defects using dorsal intercostal artery perforator flap. Ann Plast Surg 67(2):159-163, 2011
  12. Junqueira LC, Carneiro J, Kelley RO: Basic Histology. Connecticut: Appleton & Lange, 1998
  13. Kesan K, Kothari P, Gupta R, Gupta A, Karkera P, Ranjan R, Mutkhedkar K, Sandlas G: Closure of large meningomyelocele wound defects with bilateral V-Y advancement: Our experience and review of literature. Eur J Pediatr Surg 25: 189-194, 2015
  14. Komuro Y, Yanai A, Koga Y, Seno H, Inoue M: Bilateral modified V-Y advancement flaps for closing meningomyelocele defects. Ann Plast Surg 57(2):195-198, 2006
  15. Lapid O, Rosenberg L, Cohen A: Meningomyelocele reconstruction with bilobed flaps. Br J P